[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569721":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":23,"responsibleParty":43,"collaborators":45,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Kerecis Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Thor closure patients",null,"Patients who achieved closure in during the THOR clinical trial",[13,19],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Bennett Rogers","CONTACT","888-960-1343","1008","brogers@serenagroups.com",{"name":20,"role":15,"phone":21,"phoneExt":10,"email":22},"Thomas Serena, MD","814-688-4000","tserena@serenagroups.com",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Serena Group","RECRUITING","Monroeville","Pennsylvania","15146","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-79.7881,40.42118,{"lat":36,"lon":35},[39],{"name":40,"role":15,"phone":41,"phoneExt":10,"email":42},"Laura Serena","412-212-0123","lserena@serenagorups.com",{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":25,"class":47},"OTHER","100569721","evaluating-the-durability-of-closure-for-venous-leg-ulcers-100569721",false,"NCT06697925","Evaluating the Durability of Closure for Venous Leg Ulcers","Prospective Multicenter Observational Study Evaluating the Durability of Closure for Venous Leg Ulcers Following a Randomized, Controlled, Clinical Trial","THORSDOTTIR","Inclusion Criteria:\n\n* 1\\. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.\n\nExclusion Criteria:\n\n* 1\\. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.","ALL","18 Years",{"count":59,"type":60},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.",[64,65,66,67,68],"Venous Leg","Venous Leg Ulcer (VLU)","Venous Leg Ulcer","Venous Ulcer","VLU","2025-01-22",{"date":71,"type":72},"2025-01-24","ACTUAL",{"date":74,"type":60},"2025-01",{"date":76,"type":60},"2026-12",{"name":5,"class":6},1]